Resultats de la cerca - Quan Man
- Mostrar 1 - 3 resultats de 3
-
1
Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma per Yuexiang Liang, Guannan Sheng, Yu Guo, Yiping Zou, Hanhan Guo, Zhifei Li, Shaofei Chang, Quan Man, Song Gao, Jihui Hao
Publicat 2024Artigo -
2
First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors per Do, Khanh T., Chow, Laura Quan Man, Reckamp, Karen, Sanborn, Rachel E., Burris, Howard, Robert, Francisco, Camidge, D. Ross, Steuer, Conor E., Strickler, John H., Weise, Amy, Specht, Jennifer M., Gutierrez, Martin, Haughney, Peter, Hengel, Shawna, Derleth, Christina Louise, Yap, Timothy A.
Publicat 2021Text -
3
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis per Tianxing Zhou, Yongjie Xie, Xupeng Hou, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan, Zhaoyu Zhang, Yifei Wang, Hongwei Wang, Wenna Jiang, Song Gao, Tiansuo Zhao, Antao Chang, Xiuchao Wang, Hongxia Sun, Xiufeng Zhang, Shengyu Yang, Chongbiao Huang, Jihui Hao, Jing Liu
Publicat 2023Artigo
Eines de cerca:
Matèries relacionades
Biology
Cancer
Internal medicine
Medicine
Adenocarcinoma
Biochemistry
Blood pressure
Cancer research
Clinical significance
Ecology
Gemcitabine
Gene
Grading (engineering)
Immunohistochemistry
Irbesartan
Ki-67
Malignancy
Oncology
Paleontology
Pancreatic cancer
Pancreatic ductal adenocarcinoma
Pathology
Pharmacology
Stage (stratigraphy)
Survivin
Transcription factor
YAP1